Financhill
Back

Heron Therapeutics Quote, Financials, Valuation and Earnings

Heron Therapeutics Price Quote

$2.35
+0.03 (+1.29%)
(Updated: May 1, 2024 at 6:55 PM ET)

Heron Therapeutics Key Stats

Sell
29
Heron Therapeutics (HRTX) is a Sell

Day range:
$2.27 - $2.46
52-week range:
$0.50 - $3.22
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.44
P/B ratio:
0%

Volume:
2.3M
Avg. volume:
1.8M
1-year change:
-2.93%
Market cap:
$348.8M
Revenue:
$127M
EPS:
$-0.84

How Much Does Heron Therapeutics Make?

Is Heron Therapeutics Growing As A Company?

  • What Is Heron Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.14%
  • What Is Heron Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

Heron Therapeutics Stock Price Performance

What Is Heron Therapeutics 52-Week High & Low?

Heron Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Heron Therapeutics?

  • How Much Debt Does Heron Therapeutics Have?
    Total long term debt quarterly is $173.8M
  • How Much Cash Does Heron Therapeutics Have?
    Cash and short term investments quarterly total is $80.4M
  • What Is Heron Therapeutics’s Book Value Per Share?
    Book value per share is -0.23

Is Heron Therapeutics Cash Flow Positive?

  • What Is HRTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$58.8M
  • What Is Heron Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $54.1M
  • What Is Heron Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $18M

Heron Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    HRTX return on invested capital is -79.39%
  • What Is Heron Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is -49.15%
  • What Is HRTX Return On Equity?
    ROE is a measure of profitability and is 0%

Heron Therapeutics Earnings Date & Stock Price

Heron Therapeutics Competitors

  • Who Are Heron Therapeutics's Competitors?
    Below is a list of companies who compete with Heron Therapeutics or are related in some way:
    • Aldeyra Therapeutics Inc (ALDX)
    • Clearside Biomedical Inc (CLSD)
    • Esperion Therapeutics Inc (ESPR)
    • Ocular Therapeutix Inc (OCUL)
    • United Therapeutics Corp (UTHR)

Heron Therapeutics Dividend Yield

Data Unavailable

Heron Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 54.35%
Revenue: 14% 9.66%

Analyst Recommendations

Buy Recommendations: 3
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 6.75
Upside from Last Price: 190.95%

Major Shareholders

  • How many HRTX shares are owned by institutional investors?
    150.5M HRTX shares are owned by institutional investors
  • How many HRTX shares are owned by insiders?
    2.6M HRTX shares are owned by insiders